Patents for C12R 1 - Micro-organisms (92,025)
11/1992
11/03/1992US5160735 Plasminogen activator
11/03/1992US5160489 Expression vectors and method for their construction
11/03/1992CA2067598A1 Recombinant adn molecules coding for a receptor chain for the t-cell antigen, preparation process, antibody and drugs containing them
11/03/1992CA1309683C Process for preparing l(-)-carnitine chloride from 3, 4-epoxybutyric esters and novel intermediate compounds
11/03/1992CA1309680C Airlift insect cell culture
11/03/1992CA1309679C Serum free media for the growth of insect cells and expression of products thereby
11/03/1992CA1309678C Urease and method of producing the same
11/03/1992CA1309675C Recombinant dna expression vectors and dna compounds that encode isopenicillin n synthetase from penicillium chrysogenum
11/03/1992CA1309674C Signal peptide for the excretion of peptides in streptomycetes
11/03/1992CA1309673C Recombinant dna expression vectors and dna compounds which encode isopenicillin n synthetase
11/03/1992CA1309671C Monoclonal antibodies to cyclosporins
11/03/1992CA1309670C Monoclonal antibodies to mucin-like human differentiation antigens
11/03/1992CA1309613C Feed additive for animals, feed containing the said additive and process to enhance animal growth
11/03/1992CA1309588C Method for cutting plant material
11/02/1992WO1992019700A2 Continuous process for biocatalytic desulfurization of sulfur-bearing heterocyclic molecules
11/02/1992CA2109091A1 Continuous process for biocatalytic desulfurization of sulfur-bearing heterocyclic molecules
10/1992
10/31/1992WO1992019751A1 Yeast promoter and use thereof
10/31/1992CA2108966A1 Yeast promoter and its use
10/30/1992WO1992020066A1 Head suspension assembly
10/30/1992CA2109419A1 Head suspension assembly
10/30/1992CA2067590A1 Multiple hepatitis b virus surface proteins which form particles
10/30/1992CA2067405A1 Schizosaccharomyces-specific polypeptides
10/30/1992CA2067290A1 Hepatitis b virus surface proteins with reduced host carbohydrate content
10/30/1992CA2067003A1 Hbsag escape mutant vaccine
10/30/1992CA2065716A1 Biotoxicity test for chemicals
10/29/1992WO1992018627A1 Glial mitogenic factors, their preparation and use
10/29/1992WO1992018624A1 Plasmides for the expression of filamentous haemagglutinin (fha) and hosts therefor
10/29/1992WO1992018622A1 Novel proteases
10/29/1992WO1992018614A1 Autoinducer
10/29/1992WO1992018553A1 POLY-β-HYDROXY ALKANOATE (PHA) COPOLYMER, METHOD OF ITS PRODUCTION, THE MICROBE WHICH PRODUCES IT, AND PHA COPOLYMER BLEND
10/29/1992WO1992018541A1 Dna encoding mammalian phosphodiesterases
10/29/1992WO1992018530A1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN
10/29/1992WO1992016623A3 Receptors for bombesin-like peptides
10/29/1992WO1992011370A3 Polypeptides derived from proteins of the hepatitis c virus
10/29/1992WO1992006188A3 Thermostable dna polymerase
10/29/1992DE4113385A1 Hybridtransposon mit pt-operon, plasmide und bakterienstaemme dafuer Hybrid transposon with pt-operon, plasmids and bakterienstaemme for it
10/29/1992DE4111531A1 Plasmide zur fha-expression und wirte Plasmids for fha-expression and wirte
10/29/1992CA2105395A1 Autoinducer
10/28/1992EP0511011A1 Novel antibodies and methods for their use
10/28/1992EP0511003A1 Superactive GRF analogs
10/28/1992EP0510987A1 Dehalogenation of organohalogen-containing compounds
10/28/1992EP0510904A1 Novel lipophilic macrolide useful as an immunosuppressant
10/28/1992EP0510903A1 Novel lipophilic macrolide useful as an immunosuppressant
10/28/1992EP0510878A1 Human neurokinin-1 receptor
10/28/1992EP0510773A1 Canine coronavirus subunit vaccine
10/28/1992EP0510712A2 Process for the separation of the optical isomers of alpha-substituted carboxylic acids
10/28/1992EP0510693A2 Expression of human serum albumin in pichia pastoris
10/28/1992EP0510678A2 Expression of human serum albumin in pichia pastoris
10/28/1992EP0510673A2 Alkaline protease, method for producing the same, use thereof and microorganism producing the same
10/28/1992EP0510662A1 bFGF mutein and its production
10/28/1992EP0510658A2 Improvement of the secretion yield of proteins with a disulfide bridge
10/28/1992EP0510319A2 Process for increasing the performance of L-lysine secreting coryneform microorganisms
10/28/1992EP0510271A1 Novel R106 compounds
10/28/1992EP0510186A1 Therapeutic uses of melanin
10/28/1992EP0510079A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
10/28/1992EP0510075A1 Human receptor of tsh. sequence coding for such receptor
10/28/1992EP0504291A4 Novel proteins with oncostatin m activity and process for their preparation
10/28/1992EP0243485B1 Hybridoma tumor cell lines and their monoclonal antibodies to thaumatin
10/28/1992CN1065729A Monoclonal antibodies
10/28/1992CN1018846B Inosine preparing process by bacillus
10/28/1992CN1018793B Homologues of aprotinin produced from recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
10/28/1992CA2067039A1 Neurotrophic peptide derivatives
10/27/1992WO1992019373A1 Amoebae/bacteria consortia and uses for degrading wastes and contaminants
10/27/1992US5159062 Fusion polypeptides
10/27/1992US5159059 Process for reduction of certain cyclohexapeptide compounds
10/27/1992US5158939 Administering a nontoxic lipopolysaccharide from rhodopseudomonas which negate the inhibitory effects of thymus derived T suppressor cells
10/27/1992US5158937 Veterinary medicine
10/27/1992US5158887 Process for massive conversion of clostridia in synchronized cells of elongated length or refractile endospores
10/27/1992US5158886 Monoclonal antibodies specific for free N-acetylfuraminic acid and beta-glycosides and beta-glycoconjugates thereof
10/27/1992US5158885 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes
10/27/1992US5158878 Type ii restriction endonuclease swai
10/27/1992US5158875 Production of biologically active insulin-like growth factor i from high expression host cell systems
10/27/1992US5158788 Feed for aquaculture
10/27/1992CA2067304A1 Superactive grf analogs
10/27/1992CA2066992A1 Low-ash xanthan gum
10/27/1992CA2066931A1 Bfgf mutein and its production
10/27/1992CA2066926A1 Process for the separation of the optical isomers of alphasubstituted carboxylic acids
10/27/1992CA2066556A1 Alkaline protease, method for producing the same, use thereof and microorganism producing the same
10/24/1992CA2066499A1 Lipophilic macrolide useful as an immunosuppressant
10/24/1992CA2066494A1 Lipophilic macrolide useful as an immunosuppressant
10/21/1992EP0509834A2 Novel bacterial strain and method for producing theobromine using the same
10/21/1992EP0509719A1 Compounds, vectors and methods for expressing human, cytosolic phospholipase A2
10/21/1992EP0509553A1 Anti-lymphotoxin antibody, its production and use
10/21/1992EP0509056A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin
10/21/1992EP0509008A1 Biomass for the production of viruses/virus antigens.
10/21/1992EP0509006A1 Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
10/21/1992EP0508983A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
10/21/1992EP0481000A4 Receptors for fibroblast growth factors
10/21/1992EP0191827B1 Method of removing n-terminal amino acid residues from eucaryotic polypetide analogs and polypeptides produced thereby
10/21/1992CN1065490A Dna sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom
10/20/1992US5157112 Antibodies immunoreactive with the T-cell growth factor, P40
10/20/1992US5157110 Synthetic, anti-complement protein
10/20/1992US5157106 N-terminal deletions of lymphotoxin, their preparation and use
10/20/1992US5156977 Monoclonal antibodies against atrial, natriuretic peptides of humans, hybridomas & methods of use
10/20/1992US5156966 Isolating from culture of Alcaligenes microorganism
10/20/1992US5156961 Adhered to polymeri beads; treating with aqueous solution having specific gravity to separate
10/20/1992US5156960 Microbial process for the production of immunosuppressive antibiotics
10/20/1992US5156959 Introducing recombinant DNA construction into gramnegative bacteria, cultivating, recovering secreted proteins
10/20/1992US5156958 Gene encoding a 30 kilodalton outer membrane protein of bordetella pertussis and method of recombinant production of said protein
10/20/1992US5156957 Transformed mammalian cell containing an expression vector which is capable of producing a heterodimeric human fertility hormone coded by a distinct RNA